SCHEMBL923508

SCHEMBL923508

Nc1ccc(Cl)nc1Cl

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29505195 1.00
Hydrochloric Acid SCHEMBL28178818 0.97 SIRT2 (0.39)
SCHEMBL1165736 0.78
SCHEMBL29424874 0.78
SCHEMBL6869333 0.76
Hydrochloric Acid SCHEMBL10869316 0.76 IDO1 (0.42)
SCHEMBL14905844 0.74
SCHEMBL2419164 0.74
SCHEMBL857644 0.74
SCHEMBL2178190 0.74

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 522 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114716368-B Preparation method of 2-chloro-3-aminopyridine and hydrochloride thereof 上海华谊(集团)公司 2024-04-12 CN claimed
CN-114716368-A Preparation method of 2-chloro-3-aminopyridine and hydrochloride thereof 上海华谊(集团)公司 2022-07-08 CN claimed
JP-3516454-B2 2004-04-05 JP claimed
EP-0682655-A1 METHOD FOR PREPARING 3-AMINO-2-CHLORO-4-ALKYLPYRIDINE OR -4-ARYLPYRIDINE BOEHRINGER INGELHEIM KG (DE) 1995-11-22 EP claimed
WO-1995015314-A1 METHOD FOR PREPARING 3-AMINO-2-CHLORO-4-ALKYLPYRIDINE OR -4-ARYLPYRIDINE BOEHRINGER INGELHEIM KG (DE) 1995-06-08 WO claimed
JP-9227522-A None JP disclosed
US-20260125380-A1 PRMT5 INHIBITORS AND METHODS OF USE SHANGHAI APEIRON THERAPEUTICS COMPANY LIMITED (CN) 2026-05-07 US disclosed
US-20260109716-A1 CEREBLON-BASED KRAS DEGRADING PROTACS AND USES RELATED THERETO ARVINAS OPERATIONS, INC. (US) 2026-04-23 US disclosed
US-20260091048-A1 GIP RECEPTOR AGONIST COMPOUNDS LILLY CO ELI (US) 2026-04-02 US disclosed
US-20260007642-A1 INHIBITORS OF SHORT-CHAIN DEHYDROGENASE ACTIVITY FOR PROMOTING NEUROGENESIS AND INHIBITING NERVE CELL DEATH UNIV CASE WESTERN RESERVE (US) 2026-01-08 US disclosed
US-12509470-B2 Antiviral heterocyclic compounds ENANTA PHARMACEUTICALS, INC. (US) 2025-12-30 US disclosed
US-20250361244-A1 BICYCLIC HETEROCYCLYL DERIVATIVES AS IRAK4 INHIBITORS AURIGENE ONCOLOGY LTD (IN) 2025-11-27 US disclosed
US-5459138-A Dysfunctions of glutamatergic neurotransmission associated with learning and memory ADIR ET COMPAGNIE (FR) 1995-10-17 US disclosed
EP-0618209-A1 Pyridothiadiazines, processes for their preparation and pharmaceutical compositions containing them ADIR ET COMPAGNIE (FR) 1994-10-05 EP disclosed
EP-0482481-A1 Method for the preparation of 5,11-dihydro-6H-dipyrido[3,2-b:2',3'-e][1,4]diazepines BOEHRINGER INGELHEIM PHARMACEUTICALS INC. (US) 1992-04-29 EP disclosed
EP-0417534-A1 Pyrido[2,3-b][1,4]benzoxazepin (and thiazepin)-6(5H)-ones and thiones and their use in the prevention or treatment of AIDS Boehringer Ingelheim Pharmaceuticals Inc. (US) 1991-03-20 EP disclosed
EP-0100899-B1 BENZISOSELENAZOLONES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM A. Nattermann & Cie. GmbH (DE) 1988-06-15 EP disclosed
US-4550168-A Benzisoselenazolones and a process for the treatment of inflammatory diseases A. NATTERMANN & CIE GMBH (DE) 1985-10-29 US disclosed
US-4521603-A Continuous process for the production of polybromopyridine compounds OLIN CORPORATION (US) 1985-06-04 US disclosed
EP-0100899-A2 Benzisoselenazolones, process for their preparation and pharmaceutical compositions containing them A. Nattermann & Cie. GmbH (DE) 1984-02-22 EP disclosed